Roivant Sciences Ltd.
ROIV
71 insider filings · Latest: Oct 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Feb 24 1:40 AM | Frank TortiPresident and Vant Chair | Sale | 587,390 | $27.51 | $16.2M | 13,736,547(D) | View → |
| Feb 20, 2026 | Feb 24 1:40 AM | Frank TortiPresident and Vant Chair | Sale | 1,012,610 | $27.15 | $27.5M | 13,736,547(D) | View → |
| Feb 19, 2026 | Feb 24 1:40 AM | Frank TortiPresident and Vant Chair | Sale | 1,400,000 | $27.42 | $38.4M | 13,736,547(D) | View → |
| Feb 20, 2026 | Feb 20 9:29 PM | FRANK TORTI | Proposed Sale | 1,600,000 | $27.52 | $44.0M | — | View → |
| Feb 19, 2026 | Feb 19 9:24 PM | FRANK TORTI | Proposed Sale | 1,400,000 | $27.48 | $38.5M | — | View → |
| Feb 13, 2026 | Feb 18 10:57 PM | Eric VenkerPresident & Immunovant CEO | Sale | 200,000 | $26.49 | $5.3M | 1,654,597(D) | View → |
| Feb 13, 2026 | Feb 14 2:02 AM | Keith S ManchesterDirector | Sale | 375,784 | $26.50 | $10.0M | 15,127,329(I) | View → |
| Feb 12, 2026 | Feb 14 2:02 AM | Keith S ManchesterDirector | Sale | 425,000 | $26.75 | $11.4M | 15,503,113(I) | View → |
| Feb 11, 2026 | Feb 14 2:02 AM | Keith S ManchesterDirector | Sale | 425,000 | $26.67 | $11.3M | 15,928,113(I) | View → |
| Feb 13, 2026 | Feb 14 2:00 AM | Daniel Allen GoldDirector | Sale | 375,784 | $26.50 | $10.0M | 15,127,329(I) | View → |
| Feb 12, 2026 | Feb 14 2:00 AM | Daniel Allen GoldDirector | Sale | 425,000 | $26.75 | $11.4M | 15,503,113(I) | View → |
| Feb 11, 2026 | Feb 14 2:00 AM | Daniel Allen GoldDirector | Sale | 425,000 | $26.67 | $11.3M | 15,928,113(I) | View → |
| Feb 13, 2026 | Feb 14 1:45 AM | QVT Financial LPOther | Sale | 375,784 | $26.50 | $10.0M | 15,127,329(I) | View → |
| Feb 12, 2026 | Feb 14 1:45 AM | QVT Financial LPOther | Sale | 425,000 | $26.75 | $11.4M | 15,503,113(I) | View → |
| Feb 11, 2026 | Feb 14 1:45 AM | QVT Financial LPOther | Sale | 425,000 | $26.67 | $11.3M | 15,928,113(I) | View → |
| Feb 13, 2026 | Feb 13 9:21 PM | Venker Eric | Proposed Sale | 200,000 | $26.49 | $5.3M | — | View → |
| Feb 9, 2026 | Feb 11 10:53 PM | Mayukh SukhatmeDirector, President & CIO | Sale | 339,441 | $26.47 | $9.0M | 19,148,664(D) | View → |
| Feb 9, 2026 | Feb 9 9:13 PM | Sukhatme Mayukh | Proposed Sale | 339,441 | $26.47 | $9.0M | — | View → |
| Jan 12, 2026 | Jan 12 9:04 PM | Venker Eric | Proposed Sale | 200,000 | $21.92 | $4.4M | — | View → |
| Dec 31, 2025 | Dec 31 9:30 PM | Sukhatme Mayukh | Proposed Sale | 1,018,995 | $21.71 | $22.1M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Oct 5 10:05 PM | Melissa B, EpperlyDirector | Option Exercise | 17,750 | $4.46 | 151,416(D) | View → |
| Sep 30, 2026 | Oct 2 9:37 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 3,644,834(D) | View → |
| Sep 16, 2026 | Sep 19 1:00 AM | Keith S ManchesterDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 11:12 PM | Daniel Allen GoldDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 11:06 PM | Ilan OrenDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 11:01 PM | James C MomtazeeDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 10:57 PM | Meghan FitzgeraldDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 10:56 PM | Melissa B, EpperlyDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 8, 2026 | Sep 11 1:00 AM | Meghan FitzgeraldDirector | Option Exercise | 20,000 | $8.80 | 18,578(D) | View → |
| Aug 28, 2026 | Sep 2 1:00 AM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 3,844,834(D) | View → |
| Aug 21, 2026 | Aug 22 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 144,756 | $3.85 | 13,224,363(D) | View → |
| Aug 20, 2026 | Aug 22 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 17,519 | $3.85 | 13,369,119(D) | View → |
| Aug 19, 2026 | Aug 22 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 172,899 | $3.85 | 13,386,638(D) | View → |
| Aug 18, 2026 | Aug 19 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 136,942 | $3.85 | 13,559,537(D) | View → |
| Aug 17, 2026 | Aug 19 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 284,707 | $3.85 | 13,696,479(D) | View → |
| Aug 14, 2026 | Aug 19 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 243,177 | $3.85 | 13,981,186(D) | View → |
| Jul 27, 2026 | Jul 30 1:00 AM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 4,044,834(D) | View → |
| Jun 30, 2026 | Jul 2 11:03 PM | Meghan FitzgeraldDirector | Option Exercise | 10,000 | $8.80 | 38,578(D) | View → |
| Jun 29, 2026 | Jul 1 10:34 PM | Melissa B, EpperlyDirector | Option Exercise | 17,750 | $4.46 | 169,166(D) | View → |
| Jun 26, 2026 | Jun 29 10:23 PM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 500,000 | $3.85 | 14,224,363(D) | View → |
Page 1 of 2
Next →